경성대학교 산학협력단;KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION
发明人:
KANG, Jae Seon,강재선,KIM, Bo Suel,김보슬,KIM, Heyong-Soo,김형수,RHO, Gyu-Jin,노규진,BAE, Sin-Ja,배신자,LEE, Seo Hyun,이서현,PARK, Jong Jin,박종진,KIM, Choel-Min,김철민
申请号：
KRKR2016/012231
公开号：
WO2017/104966A1
申请日:
2016.10.28
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to a use of saponins of Panax ginseng such as wild ginseng, wood-cultivated ginseng, cultured roots, raw ginseng, Panax quinquefolia, Panax notoginseng, or red ginseng, and the purpose thereof is to extend cell life span, promote cell differentiation, increase red blood cell count, and decrease triglycerides. Particularly, the present invention relates to a use of saponins of Panax ginseng, which are extracted, heat-treated, and enzymatically converted so as to prepare active saponins Rd, F2, and Rg3 comprising Compound K, and contain, as main ingredients, at least 90% Compound K, Rd, F2 and Rg3, such that the saponins of Panax ginseng have effects of extending cell life span, promoting cell differentiation, increasing red blood cell count, and decreasing triglycerides.La présente invention concerne l'utilisation des saponines de Panax ginseng comme le ginseng sauvage, le ginseng cultivé dans les forêts, les racines cultivées, le ginseng brut, Panax quinquefolia, Panax notoginseng ou le ginseng rouge, afin d'augmenter la durée de vie des cellules, de favoriser la différentiation cellulaire, d'augmenter le nombre de globules rouges et de réduire les triglycérides. La présente invention concerne en particulier l'utilisation des saponines de Panax ginseng qui sont extraites, traitées par voie thermique et converties par voie enzymatique afin de préparer des saponines Rd, F2 et Rg3 actives comprenant le composé K et contenant, comme ingrédients principaux, au moins 90 % de composé K, Rd, F2 et Rg3, de manière à ce que les saponines de Panax ginseng puissent prolonger la durée de vie des cellules, favoriser la différentiation cellulaire, augmenter le nombre de globules rouges et réduire les triglycérides.본 발명은 산삼, 산양삼, 배양근, 수인삼, 화기삼, 전칠삼, 또는 홍삼 등의 인삼류 사포닌의 용도로서, 세포의 수명연장, 세포의 분화 촉진, 적혈구 수 증가, 및 중성지방 감소에 대한 것이다. 구체적으로는 상기 인삼류 사포닌을 추출하고 열처리하고 효소전환시켜 Compound K를 포함하는 활성형 사포닌 Rd, F2, Rg3를 제조하고, 이들 Compound K, Rd, F2, Rg3를 주성분으로 90% 이상 함유하여, 세포의
